Brevital Sodium
BREVITAL (methohexital sodium) for injection, USP
Approved
Approval ID
eccd8340-ead3-4363-8902-0c19d33aa2ac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 1, 2021
Manufacturers
FDA
Par Pharmaceutical, Inc.
DUNS: 092733690
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
methohexital sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code42023-105
Application NumberNDA011559
Product Classification
M
Marketing Category
C73594
G
Generic Name
methohexital sodium
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, RECTAL
Effective DateJanuary 29, 2021
FDA Product Classification
INGREDIENTS (3)
METHOHEXITAL SODIUMActive
Quantity: 500 mg in 1 1
Code: 60200PNZ7Q
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CARBONATEInactive
Code: 45P3261C7T
Classification: IACT